Inoue et al., 2001 - Google Patents
Effects of peppermint (Mentha piperita L.) extracts on experimental allergic rhinitis in ratsInoue et al., 2001
View PDF- Document ID
- 4979560793883912497
- Author
- Inoue T
- Sugimoto Y
- Masuda H
- Kamei C
- Publication year
- Publication venue
- Biological and Pharmaceutical Bulletin
External Links
Snippet
MATERIALS AND METHODS Animals Male Wistar rats (age; 7 weeks; body weight, 190— 220g) were obtained from Shimizu Laboratory Supplies (Kyoto, Japan). All of animals were maintained in an air-conditioned room with controlled temperature of 242 C and humidity of …
- 230000000694 effects 0 title description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Inoue et al. | Effects of peppermint (Mentha piperita L.) extracts on experimental allergic rhinitis in rats | |
| Kim et al. | Effect of the aqueous extract of Aquilaria agallocha stems on the immediate hypersensitivity reactions | |
| KR101183045B1 (en) | A composition for selective serotonin reuptake inhibition and process thereof | |
| DE69929330T2 (en) | NEW USE OF HIV PROTEASE INHIBITORS | |
| JPH0710875A (en) | Selective phosphodiesterase IV inhibitors | |
| JP2003531813A (en) | Naphthoquinone derivatives and their use in the treatment and control of tuberculosis | |
| JPS63188627A (en) | Antiallergic and antiphlogistic agents | |
| WO1986005180A1 (en) | Novel tannin composition | |
| EP2968217B1 (en) | Cyclohexenone compounds for treating fatty liver disease | |
| CN112451559A (en) | Use of flos Puerariae Lobatae extract in preventing and treating oxidative damage | |
| Rimar et al. | Pulmonary Protective and Vasodilator Effects of a StandardizedPanax GinsengPreparation Following Artificial Gastric Digestion | |
| Sreepriya et al. | Protective effects of Indigofera tinctoria L. against D-galactosamine and carbon tetrachloride challenge on in situ perfused rat liver | |
| CN103012560B (en) | Preparation method of cyclic peptide compound from cortex lycii radicis | |
| EP2389184A1 (en) | Anti dengue activity of cissampelos pareira extracts | |
| CN1325055C (en) | Application of stevioside R1 and its derivative as medicine for preventing and treating neurodegeneration disease | |
| JP2633609B2 (en) | Ischemic disease therapeutic agent | |
| JPH06239757A (en) | Antiallergic agent | |
| TWI373341B (en) | Antibacterial treatment and composition | |
| JP7781425B2 (en) | Methods and compositions for treating RNA viral diseases | |
| RU2094049C1 (en) | Agent improving hemo- and lymphocirculation and enhancing regenerative processes in lymph nodes at arterial ischemia | |
| JPH09208482A (en) | Airway contraction suppressant and food containing the same | |
| Shirasaki et al. | Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs | |
| JPH07165588A (en) | Brain function improving agent | |
| KR20090130633A (en) | A pharmaceutical composition for the prevention and treatment of cardiovascular diseases containing a compound isolated from the pathoscope as an active ingredient | |
| KR20020007806A (en) | Composition comprising extract of medicinal herbs for preventing and curing allergy and/or asthma |